<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns:m="http://schemas.microsoft.com/office/2004/12/omml"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 15">
<meta name=Originator content="Microsoft Word 15">
<link rel=File-List href="Go%20No-Go%20Decision_files/filelist.xml">
<link rel=Edit-Time-Data href="Go%20No-Go%20Decision_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>He, Dian (NIH/NICHD) [C]</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>He, Dian (NIH/NICHD) [C]</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>982</o:TotalTime>
  <o:Created>2026-02-01T18:08:00Z</o:Created>
  <o:LastSaved>2026-02-01T18:08:00Z</o:LastSaved>
  <o:Pages>19</o:Pages>
  <o:Words>1927</o:Words>
  <o:Characters>10985</o:Characters>
  <o:Company>NICHD</o:Company>
  <o:Lines>91</o:Lines>
  <o:Paragraphs>25</o:Paragraphs>
  <o:CharactersWithSpaces>12887</o:CharactersWithSpaces>
  <o:Version>16.00</o:Version>
 </o:DocumentProperties>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=themeData href="Go%20No-Go%20Decision_files/themedata.thmx">
<link rel=colorSchemeMapping
href="Go%20No-Go%20Decision_files/colorschememapping.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:SpellingState>Clean</w:SpellingState>
  <w:GrammarState>Clean</w:GrammarState>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>EN-US</w:LidThemeOther>
  <w:LidThemeAsian>ZH-CN</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:SplitPgBreakAndParaMark/>
   <w:EnableOpenTypeKerning/>
   <w:DontFlipMirrorIndents/>
   <w:OverrideTableStyleHps/>
   <w:UseFELayout/>
  </w:Compatibility>
  <m:mathPr>
   <m:mathFont m:val="Cambria Math"/>
   <m:brkBin m:val="before"/>
   <m:brkBinSub m:val="&#45;-"/>
   <m:smallFrac m:val="off"/>
   <m:dispDef/>
   <m:lMargin m:val="0"/>
   <m:rMargin m:val="0"/>
   <m:defJc m:val="centerGroup"/>
   <m:wrapIndent m:val="1440"/>
   <m:intLim m:val="subSup"/>
   <m:naryLim m:val="undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="false"
  DefSemiHidden="false" DefQFormat="false" DefPriority="99"
  LatentStyleCount="376">
  <w:LsdException Locked="false" Priority="0" QFormat="true" Name="Normal"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 1"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 2"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 3"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 4"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 5"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 6"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 7"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 8"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 9"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 9"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 1"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 2"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 3"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 4"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 5"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 6"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 7"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 8"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 9"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footnote text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="header"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footer"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index heading"/>
  <w:LsdException Locked="false" Priority="35" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="caption"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="table of figures"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="envelope address"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="envelope return"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footnote reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="line number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="page number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="endnote reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="endnote text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="table of authorities"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="macro"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="toa heading"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 5"/>
  <w:LsdException Locked="false" Priority="10" QFormat="true" Name="Title"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Closing"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Signature"/>
  <w:LsdException Locked="false" Priority="1" SemiHidden="true"
   UnhideWhenUsed="true" Name="Default Paragraph Font"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Message Header"/>
  <w:LsdException Locked="false" Priority="11" QFormat="true" Name="Subtitle"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Salutation"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Date"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text First Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text First Indent 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Note Heading"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Block Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Hyperlink"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="FollowedHyperlink"/>
  <w:LsdException Locked="false" Priority="22" QFormat="true" Name="Strong"/>
  <w:LsdException Locked="false" Priority="20" QFormat="true" Name="Emphasis"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Document Map"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Plain Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="E-mail Signature"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Top of Form"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Bottom of Form"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal (Web)"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Acronym"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Address"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Cite"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Code"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Definition"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Keyboard"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Preformatted"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Sample"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Typewriter"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Variable"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal Table"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation subject"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="No List"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Contemporary"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Elegant"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Professional"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Subtle 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Subtle 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Balloon Text"/>
  <w:LsdException Locked="false" Priority="39" Name="Table Grid"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Theme"/>
  <w:LsdException Locked="false" SemiHidden="true" Name="Placeholder Text"/>
  <w:LsdException Locked="false" Priority="1" QFormat="true" Name="No Spacing"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 1"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 1"/>
  <w:LsdException Locked="false" SemiHidden="true" Name="Revision"/>
  <w:LsdException Locked="false" Priority="34" QFormat="true"
   Name="List Paragraph"/>
  <w:LsdException Locked="false" Priority="29" QFormat="true" Name="Quote"/>
  <w:LsdException Locked="false" Priority="30" QFormat="true"
   Name="Intense Quote"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 1"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 1"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 2"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 2"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 2"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 3"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 3"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 3"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 4"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 4"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 4"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 5"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 5"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 5"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 6"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 6"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 6"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="19" QFormat="true"
   Name="Subtle Emphasis"/>
  <w:LsdException Locked="false" Priority="21" QFormat="true"
   Name="Intense Emphasis"/>
  <w:LsdException Locked="false" Priority="31" QFormat="true"
   Name="Subtle Reference"/>
  <w:LsdException Locked="false" Priority="32" QFormat="true"
   Name="Intense Reference"/>
  <w:LsdException Locked="false" Priority="33" QFormat="true" Name="Book Title"/>
  <w:LsdException Locked="false" Priority="37" SemiHidden="true"
   UnhideWhenUsed="true" Name="Bibliography"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="TOC Heading"/>
  <w:LsdException Locked="false" Priority="41" Name="Plain Table 1"/>
  <w:LsdException Locked="false" Priority="42" Name="Plain Table 2"/>
  <w:LsdException Locked="false" Priority="43" Name="Plain Table 3"/>
  <w:LsdException Locked="false" Priority="44" Name="Plain Table 4"/>
  <w:LsdException Locked="false" Priority="45" Name="Plain Table 5"/>
  <w:LsdException Locked="false" Priority="40" Name="Grid Table Light"/>
  <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark"/>
  <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful"/>
  <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 1"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 1"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 1"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 2"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 2"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 2"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 3"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 3"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 3"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 4"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 4"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 4"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 5"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 5"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 5"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 6"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 6"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 6"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark"/>
  <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful"/>
  <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 1"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 1"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 1"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 2"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 2"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 2"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 3"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 3"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 3"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 4"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 4"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 4"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 5"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 5"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 5"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 6"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 6"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 6"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Mention"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Smart Hyperlink"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Hashtag"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Unresolved Mention"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Smart Link"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536869121 1107305727 33554432 0 415 0;}
@font-face
	{font-family:DengXian;
	panose-1:2 1 6 0 3 1 1 1 1 1;
	mso-font-alt:\7B49\7EBF;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610612033 953122042 22 0 262159 0;}
@font-face
	{font-family:Aptos;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:536871559 3 0 0 415 0;}
@font-face
	{font-family:"Segoe UI Emoji";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 33554432 134217728 0 1 0;}
@font-face
	{font-family:"Segoe UI Symbol";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483165 302055407 262144 0 1 0;}
@font-face
	{font-family:"\@DengXian";
	panose-1:2 1 6 0 3 1 1 1 1 1;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610612033 953122042 22 0 262159 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Aptos",sans-serif;
	mso-ascii-font-family:Aptos;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:DengXian;
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Aptos;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:1.0pt;
	mso-ligatures:standardcontextual;}
h1
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 1 Char";
	mso-style-next:Normal;
	margin-top:.25in;
	margin-right:0in;
	margin-bottom:4.0pt;
	margin-left:0in;
	line-height:115%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:20.0pt;
	font-family:"Aptos Display",sans-serif;
	mso-ascii-font-family:"Aptos Display";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"DengXian Light";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Aptos Display";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#0F4761;
	mso-themecolor:accent1;
	mso-themeshade:191;
	mso-font-kerning:1.0pt;
	mso-ligatures:standardcontextual;
	font-weight:normal;}
h2
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Heading 2 Char";
	mso-style-next:Normal;
	margin-top:8.0pt;
	margin-right:0in;
	margin-bottom:4.0pt;
	margin-left:0in;
	line-height:115%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:16.0pt;
	font-family:"Aptos Display",sans-serif;
	mso-ascii-font-family:"Aptos Display";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"DengXian Light";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Aptos Display";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#0F4761;
	mso-themecolor:accent1;
	mso-themeshade:191;
	mso-font-kerning:1.0pt;
	mso-ligatures:standardcontextual;
	font-weight:normal;}
h3
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Heading 3 Char";
	mso-style-next:Normal;
	margin-top:8.0pt;
	margin-right:0in;
	margin-bottom:4.0pt;
	margin-left:0in;
	line-height:115%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:3;
	font-size:14.0pt;
	font-family:"Aptos",sans-serif;
	mso-ascii-font-family:Aptos;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"DengXian Light";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Aptos;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#0F4761;
	mso-themecolor:accent1;
	mso-themeshade:191;
	mso-font-kerning:1.0pt;
	mso-ligatures:standardcontextual;
	font-weight:normal;}
h4
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Heading 4 Char";
	mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:2.0pt;
	margin-left:0in;
	line-height:115%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:12.0pt;
	font-family:"Aptos",sans-serif;
	mso-ascii-font-family:Aptos;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"DengXian Light";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Aptos;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#0F4761;
	mso-themecolor:accent1;
	mso-themeshade:191;
	mso-font-kerning:1.0pt;
	mso-ligatures:standardcontextual;
	font-weight:normal;
	font-style:italic;}
h5
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Heading 5 Char";
	mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:2.0pt;
	margin-left:0in;
	line-height:115%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:12.0pt;
	font-family:"Aptos",sans-serif;
	mso-ascii-font-family:Aptos;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"DengXian Light";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Aptos;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#0F4761;
	mso-themecolor:accent1;
	mso-themeshade:191;
	mso-font-kerning:1.0pt;
	mso-ligatures:standardcontextual;
	font-weight:normal;}
h6
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Heading 6 Char";
	mso-style-next:Normal;
	margin-top:2.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	line-height:115%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:12.0pt;
	font-family:"Aptos",sans-serif;
	mso-ascii-font-family:Aptos;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"DengXian Light";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Aptos;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#595959;
	mso-themecolor:text1;
	mso-themetint:166;
	mso-font-kerning:1.0pt;
	mso-ligatures:standardcontextual;
	font-weight:normal;
	font-style:italic;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Heading 7 Char";
	mso-style-next:Normal;
	margin-top:2.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	line-height:115%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:7;
	font-size:12.0pt;
	font-family:"Aptos",sans-serif;
	mso-ascii-font-family:Aptos;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"DengXian Light";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Aptos;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#595959;
	mso-themecolor:text1;
	mso-themetint:166;
	mso-font-kerning:1.0pt;
	mso-ligatures:standardcontextual;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Heading 8 Char";
	mso-style-next:Normal;
	margin:0in;
	line-height:115%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:8;
	font-size:12.0pt;
	font-family:"Aptos",sans-serif;
	mso-ascii-font-family:Aptos;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"DengXian Light";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Aptos;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#272727;
	mso-themecolor:text1;
	mso-themetint:216;
	mso-font-kerning:1.0pt;
	mso-ligatures:standardcontextual;
	font-style:italic;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-qformat:yes;
	mso-style-link:"Heading 9 Char";
	mso-style-next:Normal;
	margin:0in;
	line-height:115%;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:9;
	font-size:12.0pt;
	font-family:"Aptos",sans-serif;
	mso-ascii-font-family:Aptos;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"DengXian Light";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Aptos;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#272727;
	mso-themecolor:text1;
	mso-themetint:216;
	mso-font-kerning:1.0pt;
	mso-ligatures:standardcontextual;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{mso-style-priority:10;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Title Char";
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:4.0pt;
	margin-left:0in;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:28.0pt;
	font-family:"Aptos Display",sans-serif;
	mso-ascii-font-family:"Aptos Display";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"DengXian Light";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Aptos Display";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	letter-spacing:-.5pt;
	mso-font-kerning:14.0pt;
	mso-ligatures:standardcontextual;}
p.MsoTitleCxSpFirst, li.MsoTitleCxSpFirst, div.MsoTitleCxSpFirst
	{mso-style-priority:10;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Title Char";
	mso-style-next:Normal;
	mso-style-type:export-only;
	margin:0in;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:28.0pt;
	font-family:"Aptos Display",sans-serif;
	mso-ascii-font-family:"Aptos Display";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"DengXian Light";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Aptos Display";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	letter-spacing:-.5pt;
	mso-font-kerning:14.0pt;
	mso-ligatures:standardcontextual;}
p.MsoTitleCxSpMiddle, li.MsoTitleCxSpMiddle, div.MsoTitleCxSpMiddle
	{mso-style-priority:10;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Title Char";
	mso-style-next:Normal;
	mso-style-type:export-only;
	margin:0in;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:28.0pt;
	font-family:"Aptos Display",sans-serif;
	mso-ascii-font-family:"Aptos Display";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"DengXian Light";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Aptos Display";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	letter-spacing:-.5pt;
	mso-font-kerning:14.0pt;
	mso-ligatures:standardcontextual;}
p.MsoTitleCxSpLast, li.MsoTitleCxSpLast, div.MsoTitleCxSpLast
	{mso-style-priority:10;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Title Char";
	mso-style-next:Normal;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:4.0pt;
	margin-left:0in;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:28.0pt;
	font-family:"Aptos Display",sans-serif;
	mso-ascii-font-family:"Aptos Display";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"DengXian Light";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Aptos Display";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	letter-spacing:-.5pt;
	mso-font-kerning:14.0pt;
	mso-ligatures:standardcontextual;}
p.MsoSubtitle, li.MsoSubtitle, div.MsoSubtitle
	{mso-style-priority:11;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Subtitle Char";
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:14.0pt;
	font-family:"Aptos",sans-serif;
	mso-ascii-font-family:Aptos;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"DengXian Light";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Aptos;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#595959;
	mso-themecolor:text1;
	mso-themetint:166;
	letter-spacing:.75pt;
	mso-font-kerning:1.0pt;
	mso-ligatures:standardcontextual;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.5in;
	mso-add-space:auto;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Aptos",sans-serif;
	mso-ascii-font-family:Aptos;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:DengXian;
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Aptos;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:1.0pt;
	mso-ligatures:standardcontextual;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	mso-add-space:auto;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Aptos",sans-serif;
	mso-ascii-font-family:Aptos;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:DengXian;
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Aptos;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:1.0pt;
	mso-ligatures:standardcontextual;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	mso-add-space:auto;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Aptos",sans-serif;
	mso-ascii-font-family:Aptos;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:DengXian;
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Aptos;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:1.0pt;
	mso-ligatures:standardcontextual;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:.5in;
	mso-add-space:auto;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Aptos",sans-serif;
	mso-ascii-font-family:Aptos;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:DengXian;
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Aptos;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-font-kerning:1.0pt;
	mso-ligatures:standardcontextual;}
p.MsoQuote, li.MsoQuote, div.MsoQuote
	{mso-style-priority:29;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Quote Char";
	mso-style-next:Normal;
	margin-top:8.0pt;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	text-align:center;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Aptos",sans-serif;
	mso-ascii-font-family:Aptos;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:DengXian;
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Aptos;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	color:#404040;
	mso-themecolor:text1;
	mso-themetint:191;
	mso-font-kerning:1.0pt;
	mso-ligatures:standardcontextual;
	font-style:italic;}
p.MsoIntenseQuote, li.MsoIntenseQuote, div.MsoIntenseQuote
	{mso-style-priority:30;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Intense Quote Char";
	mso-style-next:Normal;
	margin-top:.25in;
	margin-right:.6in;
	margin-bottom:.25in;
	margin-left:.6in;
	text-align:center;
	line-height:115%;
	mso-pagination:widow-orphan;
	border:none;
	mso-border-top-alt:solid #0F4761 .5pt;
	mso-border-top-themecolor:accent1;
	mso-border-top-themeshade:191;
	mso-border-bottom-alt:solid #0F4761 .5pt;
	mso-border-bottom-themecolor:accent1;
	mso-border-bottom-themeshade:191;
	padding:0in;
	mso-padding-alt:10.0pt 0in 10.0pt 0in;
	font-size:12.0pt;
	font-family:"Aptos",sans-serif;
	mso-ascii-font-family:Aptos;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:DengXian;
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Aptos;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	color:#0F4761;
	mso-themecolor:accent1;
	mso-themeshade:191;
	mso-font-kerning:1.0pt;
	mso-ligatures:standardcontextual;
	font-style:italic;}
span.MsoIntenseEmphasis
	{mso-style-priority:21;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	color:#0F4761;
	mso-themecolor:accent1;
	mso-themeshade:191;
	font-style:italic;}
span.MsoIntenseReference
	{mso-style-priority:32;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	font-variant:small-caps;
	color:#0F4761;
	mso-themecolor:accent1;
	mso-themeshade:191;
	letter-spacing:.25pt;
	font-weight:bold;}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 1";
	mso-ansi-font-size:20.0pt;
	mso-bidi-font-size:20.0pt;
	font-family:"Aptos Display",sans-serif;
	mso-ascii-font-family:"Aptos Display";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"DengXian Light";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Aptos Display";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#0F4761;
	mso-themecolor:accent1;
	mso-themeshade:191;}
span.Heading2Char
	{mso-style-name:"Heading 2 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 2";
	mso-ansi-font-size:16.0pt;
	mso-bidi-font-size:16.0pt;
	font-family:"Aptos Display",sans-serif;
	mso-ascii-font-family:"Aptos Display";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"DengXian Light";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Aptos Display";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#0F4761;
	mso-themecolor:accent1;
	mso-themeshade:191;}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 3";
	mso-ansi-font-size:14.0pt;
	mso-bidi-font-size:14.0pt;
	font-family:"DengXian Light";
	mso-fareast-font-family:"DengXian Light";
	mso-fareast-theme-font:major-fareast;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#0F4761;
	mso-themecolor:accent1;
	mso-themeshade:191;}
span.Heading4Char
	{mso-style-name:"Heading 4 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 4";
	font-family:"DengXian Light";
	mso-fareast-font-family:"DengXian Light";
	mso-fareast-theme-font:major-fareast;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#0F4761;
	mso-themecolor:accent1;
	mso-themeshade:191;
	font-style:italic;}
span.Heading5Char
	{mso-style-name:"Heading 5 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 5";
	font-family:"DengXian Light";
	mso-fareast-font-family:"DengXian Light";
	mso-fareast-theme-font:major-fareast;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#0F4761;
	mso-themecolor:accent1;
	mso-themeshade:191;}
span.Heading6Char
	{mso-style-name:"Heading 6 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 6";
	font-family:"DengXian Light";
	mso-fareast-font-family:"DengXian Light";
	mso-fareast-theme-font:major-fareast;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#595959;
	mso-themecolor:text1;
	mso-themetint:166;
	font-style:italic;}
span.Heading7Char
	{mso-style-name:"Heading 7 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 7";
	font-family:"DengXian Light";
	mso-fareast-font-family:"DengXian Light";
	mso-fareast-theme-font:major-fareast;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#595959;
	mso-themecolor:text1;
	mso-themetint:166;}
span.Heading8Char
	{mso-style-name:"Heading 8 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 8";
	font-family:"DengXian Light";
	mso-fareast-font-family:"DengXian Light";
	mso-fareast-theme-font:major-fareast;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#272727;
	mso-themecolor:text1;
	mso-themetint:216;
	font-style:italic;}
span.Heading9Char
	{mso-style-name:"Heading 9 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 9";
	font-family:"DengXian Light";
	mso-fareast-font-family:"DengXian Light";
	mso-fareast-theme-font:major-fareast;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#272727;
	mso-themecolor:text1;
	mso-themetint:216;}
span.TitleChar
	{mso-style-name:"Title Char";
	mso-style-priority:10;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Title;
	mso-ansi-font-size:28.0pt;
	mso-bidi-font-size:28.0pt;
	font-family:"Aptos Display",sans-serif;
	mso-ascii-font-family:"Aptos Display";
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"DengXian Light";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:"Aptos Display";
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	letter-spacing:-.5pt;
	mso-font-kerning:14.0pt;}
span.SubtitleChar
	{mso-style-name:"Subtitle Char";
	mso-style-priority:11;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Subtitle;
	mso-ansi-font-size:14.0pt;
	mso-bidi-font-size:14.0pt;
	font-family:"DengXian Light";
	mso-fareast-font-family:"DengXian Light";
	mso-fareast-theme-font:major-fareast;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#595959;
	mso-themecolor:text1;
	mso-themetint:166;
	letter-spacing:.75pt;}
span.QuoteChar
	{mso-style-name:"Quote Char";
	mso-style-priority:29;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Quote;
	color:#404040;
	mso-themecolor:text1;
	mso-themetint:191;
	font-style:italic;}
span.IntenseQuoteChar
	{mso-style-name:"Intense Quote Char";
	mso-style-priority:30;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Intense Quote";
	color:#0F4761;
	mso-themecolor:accent1;
	mso-themeshade:191;
	font-style:italic;}
span.SpellE
	{mso-style-name:"";
	mso-spl-e:yes;}
span.GramE
	{mso-style-name:"";
	mso-gram-e:yes;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-size:12.0pt;
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Aptos",sans-serif;
	mso-ascii-font-family:Aptos;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:DengXian;
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Aptos;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
.MsoPapDefault
	{mso-style-type:export-only;
	margin-bottom:8.0pt;
	line-height:115%;}
@page WordSection1
	{size:8.5in 11.0in;
	margin:1.0in 1.0in 1.0in 1.0in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 @list l0
	{mso-list-id:41371642;
	mso-list-template-ids:-226832974;}
@list l0:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l0:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l0:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l0:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l0:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l0:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l0:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l0:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l0:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l1
	{mso-list-id:58554107;
	mso-list-template-ids:-1729748254;}
@list l1:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l1:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l1:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l1:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l1:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l1:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l1:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l1:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l1:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l2
	{mso-list-id:121462741;
	mso-list-template-ids:1535402240;}
@list l2:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l2:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l2:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l2:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l2:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l2:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l2:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l2:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l2:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l3
	{mso-list-id:225456574;
	mso-list-template-ids:148567802;}
@list l3:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l3:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l3:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l3:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l3:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l3:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l3:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l3:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l3:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l4
	{mso-list-id:225650775;
	mso-list-template-ids:1936328774;}
@list l4:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l4:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l4:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l4:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l4:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l4:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l4:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l4:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l4:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l5
	{mso-list-id:426079172;
	mso-list-template-ids:-870815522;}
@list l5:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l5:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l5:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l5:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l5:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l5:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l5:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l5:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l5:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l6
	{mso-list-id:435057319;
	mso-list-template-ids:2063078258;}
@list l6:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l6:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l6:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l6:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l6:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l6:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l6:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l6:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l6:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l7
	{mso-list-id:499584422;
	mso-list-template-ids:-1903114280;}
@list l7:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l7:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l7:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l7:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l7:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l7:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l7:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l7:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l7:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l8
	{mso-list-id:557858538;
	mso-list-template-ids:-1576260518;}
@list l8:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l8:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l8:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l8:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l8:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l8:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l8:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l8:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l8:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l9
	{mso-list-id:592662392;
	mso-list-template-ids:107398054;}
@list l9:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l9:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l9:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l9:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l9:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l9:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l9:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l9:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l9:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l10
	{mso-list-id:764420204;
	mso-list-template-ids:466098444;}
@list l10:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l10:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l10:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l10:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l10:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l10:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l10:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l10:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l10:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l11
	{mso-list-id:1075396722;
	mso-list-template-ids:492315682;}
@list l11:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l11:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l11:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l11:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l11:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l11:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l11:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l11:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l11:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l12
	{mso-list-id:1370296343;
	mso-list-template-ids:-246640910;}
@list l12:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l12:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l12:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l12:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l12:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l12:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l12:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l12:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l12:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l13
	{mso-list-id:1589997217;
	mso-list-template-ids:-947995462;}
@list l13:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l13:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l13:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l13:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l13:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l13:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l13:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l13:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l13:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l14
	{mso-list-id:1593510615;
	mso-list-template-ids:498629978;}
@list l14:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l14:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l14:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l14:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l14:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l14:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l14:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l14:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l14:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l15
	{mso-list-id:1661228750;
	mso-list-template-ids:-700446236;}
@list l15:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l15:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l15:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l15:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l15:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l15:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l15:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l15:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l15:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l16
	{mso-list-id:1802728536;
	mso-list-template-ids:930394564;}
@list l16:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l16:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l16:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l16:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l16:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l16:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l16:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l16:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l16:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l17
	{mso-list-id:1836022993;
	mso-list-template-ids:2024679734;}
@list l17:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l17:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l17:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l17:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l17:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l17:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l17:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l17:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l17:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l18
	{mso-list-id:1858420212;
	mso-list-template-ids:393396854;}
@list l18:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l18:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l18:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l18:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l18:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l18:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l18:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l18:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l18:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l19
	{mso-list-id:1868254654;
	mso-list-template-ids:1526759172;}
@list l19:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l19:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l19:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l19:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l19:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l19:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l19:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l19:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l19:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l20
	{mso-list-id:2046363083;
	mso-list-template-ids:-248488208;}
@list l20:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l20:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l20:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l20:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l20:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l20:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l20:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l20:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l20:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l21
	{mso-list-id:2073117853;
	mso-list-template-ids:4885426;}
@list l21:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Symbol;}
@list l21:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l21:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l21:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l21:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l21:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l21:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l21:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
@list l21:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	font-family:Wingdings;}
ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin-top:0in;
	mso-para-margin-right:0in;
	mso-para-margin-bottom:8.0pt;
	mso-para-margin-left:0in;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Aptos",sans-serif;
	mso-ascii-font-family:Aptos;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Aptos;
	mso-hansi-theme-font:minor-latin;
	mso-font-kerning:1.0pt;
	mso-ligatures:standardcontextual;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1026"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in;word-wrap:break-word'>

<div class=WordSection1>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><b>Phase II Single-Tumor Example:<o:p></o:p></b></p>

<p class=MsoNormal><b>Go / No-Go Decision for Phase III<o:p></o:p></b></p>

<p class=MsoNormal><b>Case Study: IMvigor210 &#8594; Decision to Proceed to
Phase III<o:p></o:p></b></p>

<p class=MsoNormal><b>Indication:</b> Metastatic urothelial carcinoma (<span
class=SpellE>mUC</span>)<br>
<b>Line of therapy:</b> Post-platinum (2L+)<br>
<b>Investigational drug:</b> Atezolizumab (antiPD-L1)<br>
<b>Study phase:</b> Phase II<br>
<b>Design:</b> Single-arm, open-label<br>
<b>Assessment:</b> RECIST 1.1 with BICR</p>

<p class=MsoNormal>This is a <b>classic real-world example</b> of a Phase II
study that directly triggered the question:</p>

<p class=MsoNormal><b>Is this strong enough to justify a Phase III trial?</b></p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" align=center>

</div>

<p class=MsoNormal><b>Key Phase II Results (at decision time)<o:p></o:p></b></p>

<p class=MsoNormal><b>IMvigor210  Cohort 2</b></p>

<ul style='margin-top:0in' type=disc>
 <li class=MsoNormal style='mso-list:l10 level1 lfo1;tab-stops:list .5in'><b>ORR:</b>
     15% (95% CI: 1119%)</li>
 <li class=MsoNormal style='mso-list:l10 level1 lfo1;tab-stops:list .5in'><b>CR
     rate:</b> ~5%</li>
 <li class=MsoNormal style='mso-list:l10 level1 lfo1;tab-stops:list .5in'><b>Median
     <span class=SpellE>DoR</span>:</b> Not reached</li>
 <li class=MsoNormal style='mso-list:l10 level1 lfo1;tab-stops:list .5in'><b>12-month
     <span class=SpellE>DoR</span> rate:</b> ~84%</li>
 <li class=MsoNormal style='mso-list:l10 level1 lfo1;tab-stops:list .5in'><b>Grade
     &#8805;3 TRAE:</b> ~16%</li>
 <li class=MsoNormal style='mso-list:l10 level1 lfo1;tab-stops:list .5in'><b>Historical
     ORR (2L <span class=SpellE>mUC</span>):</b> ~10%</li>
</ul>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" align=center>

</div>

<p class=MsoNormal><b>Go / No-Go Evaluation Using a Structured Checklist<o:p></o:p></b></p>

<p class=MsoNormal><b>A. Efficacy Signal<o:p></o:p></b></p>

<table class=MsoNormalTable border=0 cellspacing=3 cellpadding=0
 style='mso-cellspacing:1.5pt;mso-yfti-tbllook:1184'>
 <thead>
  <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b>Criterion<o:p></o:p></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b>Assessment<o:p></o:p></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b>Rationale<o:p></o:p></b></p>
   </td>
  </tr>
 </thead>
 <tr style='mso-yfti-irow:1'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>ORR magnitude</p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b>Borderline</b></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>15% vs ~10% historical control; modest absolute
  improvement</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>CI lower bound</p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b>Risk / Borderline</b></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Lower bound close to historical response</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span class=SpellE>DoR</span> durability</p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b>Go (key strength)</b></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Median <span class=SpellE>DoR</span> not reached;
  responses were long-lasting</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>CR presence</p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b>Go</b></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Presence of CR supports biological activity</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:5;mso-yfti-lastrow:yes'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Consistency across endpoints</p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b>Borderline</b></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>ORR modest; durability strong</p>
  </td>
 </tr>
</table>

<p class=MsoNormal><b>Module conclusion:</b> <b>Borderline</b>, supported
primarily by <span class=SpellE><b>DoR</b></span></p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" align=center>

</div>

<p class=MsoNormal><b>B. Consistency and Robustness<o:p></o:p></b></p>

<table class=MsoNormalTable border=0 cellspacing=3 cellpadding=0
 style='mso-cellspacing:1.5pt;mso-yfti-tbllook:1184'>
 <thead>
  <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b>Criterion<o:p></o:p></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b>Assessment<o:p></o:p></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b>Rationale<o:p></o:p></b></p>
   </td>
  </tr>
 </thead>
 <tr style='mso-yfti-irow:1'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Multicenter consistency</p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b>Go</b></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Responses observed across sites</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Subgroup consistency</p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b>Borderline</b></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Higher PD-L1 expression associated with better response</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Independent review (BICR)</p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b>Go</b></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Reduced assessment bias</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4;mso-yfti-lastrow:yes'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Sensitivity analyses</p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b>Borderline</b></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>ORR sensitive to assumptions</p>
  </td>
 </tr>
</table>

<p class=MsoNormal><b>Module conclusion:</b> <b>Borderline &#8594; Go</b></p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" align=center>

</div>

<p class=MsoNormal><b>C. Biological Plausibility<o:p></o:p></b></p>

<table class=MsoNormalTable border=0 cellspacing=3 cellpadding=0
 style='mso-cellspacing:1.5pt;mso-yfti-tbllook:1184'>
 <thead>
  <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b>Criterion<o:p></o:p></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b>Assessment<o:p></o:p></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b>Rationale<o:p></o:p></b></p>
   </td>
  </tr>
 </thead>
 <tr style='mso-yfti-irow:1'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Mechanism of action</p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b>Go</b></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>PD-L1 pathway well-established in <span class=SpellE>mUC</span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Biomarker support</p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b>Borderline</b></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>PD-L1 enrichment helpful but not definitive</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3;mso-yfti-lastrow:yes'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Exposureresponse</p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b>Not critical</b></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Platform antibody with prior knowledge</p>
  </td>
 </tr>
</table>

<p class=MsoNormal><b>Module conclusion:</b> <b>Go</b></p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" align=center>

</div>

<p class=MsoNormal><b>D. Safety and RiskBenefit<o:p></o:p></b></p>

<table class=MsoNormalTable border=0 cellspacing=3 cellpadding=0
 style='mso-cellspacing:1.5pt;mso-yfti-tbllook:1184'>
 <thead>
  <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b>Criterion<o:p></o:p></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b>Assessment<o:p></o:p></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b>Rationale<o:p></o:p></b></p>
   </td>
  </tr>
 </thead>
 <tr style='mso-yfti-irow:1'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Grade &#8805;3 TRAE</p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b>Go</b></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Manageable and expected for class</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Serious safety signals</p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b>Go</b></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>No unexpected safety concerns</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Discontinuation due to AE</p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b>Go</b></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Acceptable</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4;mso-yfti-lastrow:yes'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Overall riskbenefit</p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b>Borderline &#8594; Go</b></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Benefit driven mainly by durable responses</p>
  </td>
 </tr>
</table>

<p class=MsoNormal><b>Module conclusion:</b> <b>Go</b></p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" align=center>

</div>

<p class=MsoNormal><b>E. Phase III Feasibility (Critical Gate)<o:p></o:p></b></p>

<table class=MsoNormalTable border=0 cellspacing=3 cellpadding=0
 style='mso-cellspacing:1.5pt;mso-yfti-tbllook:1184'>
 <thead>
  <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b>Criterion<o:p></o:p></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b>Assessment<o:p></o:p></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b>Rationale<o:p></o:p></b></p>
   </td>
  </tr>
 </thead>
 <tr style='mso-yfti-irow:1'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Control arm</p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b>Go</b></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Chemotherapy standard available</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Primary endpoint</p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b>Go</b></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Overall survival feasible</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Sample size</p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b>Go</b></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Achievable</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4;mso-yfti-lastrow:yes'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Recruitment</p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b>Go</b></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>High unmet need population</p>
  </td>
 </tr>
</table>

<p class=MsoNormal><b>Module conclusion:</b> <b>Go</b></p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" align=center>

</div>

<p class=MsoNormal><b>F. Regulatory and Strategic Fit<o:p></o:p></b></p>

<table class=MsoNormalTable border=0 cellspacing=3 cellpadding=0
 style='mso-cellspacing:1.5pt;mso-yfti-tbllook:1184'>
 <thead>
  <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b>Criterion<o:p></o:p></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b>Assessment<o:p></o:p></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b>Rationale<o:p></o:p></b></p>
   </td>
  </tr>
 </thead>
 <tr style='mso-yfti-irow:1'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Accelerated approval potential</p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b>Go</b></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>ORR + durable <span class=SpellE>DoR</span> acceptable to
  regulators</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Confirmatory pathway</p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b>Go</b></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Phase III OS study defined</p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3;mso-yfti-lastrow:yes'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Portfolio priority</p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b>Go</b></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal>Core oncology asset</p>
  </td>
 </tr>
</table>

<p class=MsoNormal><b>Module conclusion:</b> <b>Go</b></p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" align=center>

</div>

<p class=MsoNormal><b>Final Go / No-Go Decision (at the time)<o:p></o:p></b></p>

<p class=MsoNormal><b>Decision: GO &#8594; Proceed to Phase III (IMvigor211)</b></p>

<p class=MsoNormal><b>Rationale:</b></p>

<ul style='margin-top:0in' type=disc>
 <li class=MsoNormal style='mso-list:l13 level1 lfo2;tab-stops:list .5in'>ORR
     was modest but <b>durability was compelling</b></li>
 <li class=MsoNormal style='mso-list:l13 level1 lfo2;tab-stops:list .5in'>Safety
     acceptable</li>
 <li class=MsoNormal style='mso-list:l13 level1 lfo2;tab-stops:list .5in'>Phase
     III design feasible</li>
 <li class=MsoNormal style='mso-list:l13 level1 lfo2;tab-stops:list .5in'>Immunotherapy
     long-tail benefit hypothesis</li>
</ul>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" align=center>

</div>

<p class=MsoNormal><b>Post-hoc Outcome (Critical Learning)<o:p></o:p></b></p>

<ul style='margin-top:0in' type=disc>
 <li class=MsoNormal style='mso-list:l15 level1 lfo3;tab-stops:list .5in'><b>Phase
     III IMvigor211 failed to meet the primary OS endpoint</b></li>
 <li class=MsoNormal style='mso-list:l15 level1 lfo3;tab-stops:list .5in'>Retrospective
     interpretation:</li>
 <ul style='margin-top:0in' type=circle>
  <li class=MsoNormal style='mso-list:l15 level2 lfo3;tab-stops:list 1.0in'>Phase
      II ORR improvement was <b>too small</b></li>
  <li class=MsoNormal style='mso-list:l15 level2 lfo3;tab-stops:list 1.0in'>Phase
      II signal relied heavily on <span class=SpellE><b>DoR</b></span><b> alone</b></li>
  <li class=MsoNormal style='mso-list:l15 level2 lfo3;tab-stops:list 1.0in'>Biomarker
      stratification assumptions were optimistic</li>
 </ul>
</ul>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" align=center>

</div>

<p class=MsoNormal><b>Key Takeaway for Decision-Making<o:p></o:p></b></p>

<p class=MsoNormal><b>A Phase II study can justify a Phase III trial even when
the decision is reasonable but risky.<br>
Strong durability cannot always compensate for a marginal response rate.</b></p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" align=center>

</div>

<p class=MsoNormal><b>One-Sentence Summary<o:p></o:p></b></p>

<p class=MsoNormal><b>In single-tumor Phase II trials, the decision to proceed
to Phase III hinges not on whether there is a highlight, but on whether the
weakest link in the evidence chain can support a large, confirmatory trial.</b></p>

<p class=MsoNormal><o:p>&nbsp;</o:p></p>

<span style='font-size:12.0pt;line-height:115%;font-family:"Aptos",sans-serif;
mso-ascii-theme-font:minor-latin;mso-fareast-font-family:DengXian;mso-fareast-theme-font:
minor-fareast;mso-hansi-theme-font:minor-latin;mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:minor-bidi;color:#0070C0;mso-ansi-language:EN-US;
mso-fareast-language:ZH-CN;mso-bidi-language:AR-SA'><br clear=all
style='mso-special-character:line-break;page-break-before:always'>
</span>

<p class=MsoNormal><span style='color:#0070C0'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><span style='color:#0070C0'>Phase II: More focused on ORR / <span
class=SpellE>DoR</span> (tumor reduction and duration)<o:p></o:p></span></p>

<p class=MsoNormal><span style='color:#0070C0'>Phase III: More focused on OS /
PFS (survival outcomes) <o:p></o:p></span></p>

<p class=MsoNormal><span style='color:#0070C0'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><span style='color:#0070C0'>Go/No-Go Decision:<o:p></o:p></span></p>

<p class=MsoNormal><span style='color:#0070C0'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><span style='font-family:"Segoe UI Symbol",sans-serif;
mso-bidi-font-family:"Segoe UI Symbol";color:#0070C0'>&#10004;</span><span
style='color:#0070C0'> The framework must be defined in advance.<o:p></o:p></span></p>

<p class=MsoNormal><span style='color:#0070C0'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><span style='font-family:"Segoe UI Symbol",sans-serif;
mso-bidi-font-family:"Segoe UI Symbol";color:#0070C0'>&#10004;</span><span
style='color:#0070C0'> The metrics must be defined in advance.<o:p></o:p></span></p>

<p class=MsoNormal><span style='color:#0070C0'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><span style='font-family:"Segoe UI Symbol",sans-serif;
mso-bidi-font-family:"Segoe UI Symbol";color:#0070C0'>&#10004;</span><span
style='color:#0070C0'> Thresholds can be defined as ranges/levels.<o:p></o:p></span></p>

<p class=MsoNormal><span style='color:#0070C0'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><span class=GramE><span style='font-family:"Segoe UI Emoji",sans-serif;
mso-bidi-font-family:"Segoe UI Emoji";color:#0070C0'>&#10060;</span><span
style='color:#0070C0'><span style='mso-spacerun:yes'> </span>Rules</span></span><span
style='color:#0070C0'> cannot be &quot;invented&quot; after the data is
available. <o:p></o:p></span></p>

<span style='font-size:12.0pt;line-height:115%;font-family:"Aptos",sans-serif;
mso-ascii-theme-font:minor-latin;mso-fareast-font-family:DengXian;mso-fareast-theme-font:
minor-fareast;mso-hansi-theme-font:minor-latin;mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:minor-bidi;color:#0070C0;mso-ansi-language:EN-US;
mso-fareast-language:ZH-CN;mso-bidi-language:AR-SA'><br clear=all
style='mso-special-character:line-break;page-break-before:always'>
</span>

<p class=MsoNormal><span style='color:#0070C0'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><span style='color:#0070C0'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
mso-themecolor:text1'>(Summary of Experience)<o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
mso-themecolor:text1'>If the Phase I sample size is <span class=GramE>small</span>
but the signal is strong and the mechanism is clear, prioritize a single-dose
main cohort plus a small exploratory cohort. This represents a compromise
between efficiency and risk.<o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
mso-themecolor:text1'>If Phase I shows significant non-linear PK or PD that has
not reached a plateau, do not rush to determine a single dose; it is safer to
include dose-finding in Phase II.<o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
mso-themecolor:text1'>For immunotherapy or drugs with long-term administration,
chronic toxicity is particularly important. The recommended Phase 2 dose (RP2D)
is often chosen at a dose lower than the maximum tolerated dose (MTD); continue
monitoring and retain room for adjustment in Phase II.<o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
mso-themecolor:text1'>All &quot;if...then...&quot; trigger conditions must be
actionable, auditable, and quantified as much as possible (e.g., increase in
ORR, proportion of Grade </span><span lang=ZH-CN style='font-family:DengXian;
mso-ascii-font-family:Aptos;mso-ascii-theme-font:minor-latin;mso-fareast-theme-font:
minor-fareast;mso-hansi-font-family:Aptos;mso-hansi-theme-font:minor-latin;
color:black;mso-themecolor:text1'>&#8805;</span><span style='color:black;
mso-themecolor:text1'>3 TRAEs, PK <span class=SpellE>Ctrough</span>
differences, etc.).<span style='mso-tab-count:1'> </span><o:p></o:p></span></p>

<span style='font-size:12.0pt;line-height:115%;font-family:"Aptos",sans-serif;
mso-ascii-theme-font:minor-latin;mso-fareast-font-family:DengXian;mso-fareast-theme-font:
minor-fareast;mso-hansi-theme-font:minor-latin;mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:minor-bidi;color:black;mso-themecolor:text1;mso-ansi-language:
EN-US;mso-fareast-language:ZH-CN;mso-bidi-language:AR-SA'><br clear=all
style='mso-special-character:line-break;page-break-before:always'>
</span>

<p class=MsoNormal><span style='color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='tab-stops:92.0pt'><b><span style='color:black;
mso-themecolor:text1'>Phase II Dose Strategy vs Risk Reduction Matrix<o:p></o:p></span></b></p>

<table class=MsoNormalTable border=0 cellspacing=3 cellpadding=0
 style='mso-cellspacing:1.5pt;mso-yfti-tbllook:1184'>
 <thead>
  <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal style='tab-stops:92.0pt'><b><span style='color:black;
   mso-themecolor:text1'>Phase II Dose Strategy<o:p></o:p></span></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal style='tab-stops:92.0pt'><b><span style='color:black;
   mso-themecolor:text1'>Description<o:p></o:p></span></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal style='tab-stops:92.0pt'><b><span style='color:black;
   mso-themecolor:text1'>Dose Uncertainty Reduced<o:p></o:p></span></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal style='tab-stops:92.0pt'><b><span style='color:black;
   mso-themecolor:text1'>Safety Risk Reduced<o:p></o:p></span></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal style='tab-stops:92.0pt'><b><span style='color:black;
   mso-themecolor:text1'>Efficacy Risk Reduced<o:p></o:p></span></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal style='tab-stops:92.0pt'><b><span style='color:black;
   mso-themecolor:text1'>Cost / Operational Complexity<o:p></o:p></span></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal style='tab-stops:92.0pt'><b><span style='color:black;
   mso-themecolor:text1'>Typical Use Case<o:p></o:p></span></b></p>
   </td>
  </tr>
 </thead>
 <tr style='mso-yfti-irow:1'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><b><span style='color:black;
  mso-themecolor:text1'>Single RP2D Only</span></b><span style='color:black;
  mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
  mso-themecolor:text1'>One RP2D used for all patients<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
  mso-themecolor:text1'>&#9679;<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
  mso-themecolor:text1'>&#9679;<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
  mso-themecolor:text1'>&#9679;<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='font-family:"Segoe UI Symbol",sans-serif;
  mso-bidi-font-family:"Segoe UI Symbol";color:black;mso-themecolor:text1'>&#9733;</span><span
  style='color:black;mso-themecolor:text1'> (Lowest)<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
  mso-themecolor:text1'>Phase I shows clear PK/PD plateau, strong efficacy
  signal, wide safety margin<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><b><span style='color:black;
  mso-themecolor:text1'>RP2D + Exploratory Cohort</span></b><span
  style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
  mso-themecolor:text1'>Main cohort at RP2D plus small cohort at adjacent dose<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
  mso-themecolor:text1'>&#9679;&#9679;<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
  mso-themecolor:text1'>&#9679;&#9679;<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
  mso-themecolor:text1'>&#9679;&#9679;<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='font-family:"Segoe UI Symbol",sans-serif;
  mso-bidi-font-family:"Segoe UI Symbol";color:black;mso-themecolor:text1'>&#9733;&#9733;</span><span
  style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
  mso-themecolor:text1'>Mild residual uncertainty around optimal dose; low-cost
  confirmation needed<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><b><span style='color:black;
  mso-themecolor:text1'>Randomized Dose Selection</span></b><span
  style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
  mso-themecolor:text1'>Two doses randomized (e.g., 300 vs 350 mg)<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
  mso-themecolor:text1'>&#9679;&#9679;&#9679;<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
  mso-themecolor:text1'>&#9679;&#9679;&#9679;<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
  mso-themecolor:text1'>&#9679;&#9679;&#9679;<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='font-family:"Segoe UI Symbol",sans-serif;
  mso-bidi-font-family:"Segoe UI Symbol";color:black;mso-themecolor:text1'>&#9733;&#9733;&#9733;</span><span
  style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
  mso-themecolor:text1'>Doseresponse uncertainty could materially impact Phase
  III success<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><b><span style='color:black;
  mso-themecolor:text1'>Adaptive / Bayesian Dose Optimization</span></b><span
  style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
  mso-themecolor:text1'>Dynamic allocation to better-performing dose(s)<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
  mso-themecolor:text1'>&#9679;&#9679;&#9679;&#9679;<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
  mso-themecolor:text1'>&#9679;&#9679;&#9679;&#9679;<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
  mso-themecolor:text1'>&#9679;&#9679;&#9679;&#9679;<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='font-family:"Segoe UI Symbol",sans-serif;
  mso-bidi-font-family:"Segoe UI Symbol";color:black;mso-themecolor:text1'>&#9733;&#9733;&#9733;&#9733;</span><span
  style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
  mso-themecolor:text1'>Complex <span class=SpellE>MoA</span>, narrow
  therapeutic window, very high Phase III stakes<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:5'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><b><span style='color:black;
  mso-themecolor:text1'>Schedule / Dose Strategy Evaluation</span></b><span
  style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
  mso-themecolor:text1'>Same dose, different schedules or dose-modification
  rules<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
  mso-themecolor:text1'>&#9679;&#9679;<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
  mso-themecolor:text1'>&#9679;&#9679;&#9679;<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
  mso-themecolor:text1'>&#9679;<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='font-family:"Segoe UI Symbol",sans-serif;
  mso-bidi-font-family:"Segoe UI Symbol";color:black;mso-themecolor:text1'>&#9733;&#9733;</span><span
  style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
  mso-themecolor:text1'>Primary concern is chronic toxicity or tolerability
  rather than peak exposure<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:6;mso-yfti-lastrow:yes'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><b><span style='color:black;
  mso-themecolor:text1'>Seamless Phase I/II Dose Expansion</span></b><span
  style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
  mso-themecolor:text1'>Continued multi-dose learning during expansion<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
  mso-themecolor:text1'>&#9679;&#9679;&#9679;<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
  mso-themecolor:text1'>&#9679;&#9679;<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
  mso-themecolor:text1'>&#9679;&#9679;<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='font-family:"Segoe UI Symbol",sans-serif;
  mso-bidi-font-family:"Segoe UI Symbol";color:black;mso-themecolor:text1'>&#9733;&#9733;</span><span
  style='mso-ascii-font-family:Aptos;mso-hansi-font-family:Aptos;mso-bidi-font-family:
  Aptos;color:black;mso-themecolor:text1'></span><span style='font-family:
  "Segoe UI Symbol",sans-serif;mso-bidi-font-family:"Segoe UI Symbol";
  color:black;mso-themecolor:text1'>&#9733;&#9733;&#9733;</span><span
  style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
  mso-themecolor:text1'>Strong early signal but remaining uncertainty in
  optimal dose<o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='tab-stops:92.0pt'><b><span style='color:black;
mso-themecolor:text1'>Legend</span></b><span style='color:black;mso-themecolor:
text1'><o:p></o:p></span></p>

<ul style='margin-top:0in' type=disc>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l12 level1 lfo19;
     tab-stops:list .5in left 92.0pt'>&#9679; = Low<o:p></o:p></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l12 level1 lfo19;
     tab-stops:list .5in left 92.0pt'>&#9679;&#9679; = Moderate<o:p></o:p></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l12 level1 lfo19;
     tab-stops:list .5in left 92.0pt'>&#9679;&#9679;&#9679; = High<o:p></o:p></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l12 level1 lfo19;
     tab-stops:list .5in left 92.0pt'>&#9679;&#9679;&#9679;&#9679; = Very high<o:p></o:p></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l12 level1 lfo19;
     tab-stops:list .5in left 92.0pt'><span style='font-family:"Segoe UI Symbol",sans-serif;
     mso-bidi-font-family:"Segoe UI Symbol"'>&#9733;</span> = Relative cost /
     complexity (more <span style='font-family:"Segoe UI Symbol",sans-serif;
     mso-bidi-font-family:"Segoe UI Symbol"'>&#9733;</span> = higher)<o:p></o:p></li>
</ul>

<div class=MsoNormal align=center style='text-align:center;tab-stops:92.0pt'><span
style='color:black;mso-themecolor:text1'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal style='tab-stops:92.0pt'><b><span style='color:black;
mso-themecolor:text1'>How to Use This Table for Decision-Making<o:p></o:p></span></b></p>

<p class=MsoNormal style='tab-stops:92.0pt'><b><span style='color:black;
mso-themecolor:text1'>1&#65039;</span></b><b><span style='font-family:"Segoe UI Symbol",sans-serif;
mso-bidi-font-family:"Segoe UI Symbol";color:black;mso-themecolor:text1'>&#8419;</span><span
style='color:black;mso-themecolor:text1'> Assess Residual Dose Uncertainty<o:p></o:p></span></b></p>

<p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
mso-themecolor:text1'>Ask:<o:p></o:p></span></p>

<ul style='margin-top:0in' type=disc>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l1 level1 lfo20;
     tab-stops:list .5in left 92.0pt'>Is PK/PD fully saturated at the RP2D?<o:p></o:p></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l1 level1 lfo20;
     tab-stops:list .5in left 92.0pt'>Is there evidence of cumulative or
     dose-sensitive toxicity?<o:p></o:p></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l1 level1 lfo20;
     tab-stops:list .5in left 92.0pt'>Could a suboptimal dose materially affect
     Phase III outcomes?<o:p></o:p></li>
</ul>

<div class=MsoNormal align=center style='text-align:center;tab-stops:92.0pt'><span
style='color:black;mso-themecolor:text1'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal style='tab-stops:92.0pt'><b><span style='color:black;
mso-themecolor:text1'>2&#65039;</span></b><b><span style='font-family:"Segoe UI Symbol",sans-serif;
mso-bidi-font-family:"Segoe UI Symbol";color:black;mso-themecolor:text1'>&#8419;</span><span
style='color:black;mso-themecolor:text1'> Match Strategy to Risk Profile<o:p></o:p></span></b></p>

<ul style='margin-top:0in' type=disc>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l18 level1 lfo21;
     tab-stops:list .5in left 92.0pt'><b>Low uncertainty</b> &#8594; <i>Single
     RP2D</i><o:p></o:p></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l18 level1 lfo21;
     tab-stops:list .5in left 92.0pt'><b>Moderate uncertainty</b> &#8594; <i>RP2D
     + exploratory cohort</i><o:p></o:p></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l18 level1 lfo21;
     tab-stops:list .5in left 92.0pt'><b>High uncertainty + high Phase III cost</b>
     &#8594; <i>Randomized or adaptive dose selection</i><o:p></o:p></li>
</ul>

<div class=MsoNormal align=center style='text-align:center;tab-stops:92.0pt'><span
style='color:black;mso-themecolor:text1'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal style='tab-stops:92.0pt'><b><span style='color:black;
mso-themecolor:text1'>3&#65039;</span></b><b><span style='font-family:"Segoe UI Symbol",sans-serif;
mso-bidi-font-family:"Segoe UI Symbol";color:black;mso-themecolor:text1'>&#8419;</span><span
style='color:black;mso-themecolor:text1'> Avoid Over-Engineering<o:p></o:p></span></b></p>

<p class=MsoNormal style='tab-stops:92.0pt'><b><span style='color:black;
mso-themecolor:text1'>Not every program needs maximal risk reduction<br>
only enough to make Phase III a rational investment.</span></b><span
style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>

<div class=MsoNormal align=center style='text-align:center;tab-stops:92.0pt'><span
style='color:black;mso-themecolor:text1'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal style='tab-stops:92.0pt'><b><span style='color:black;
mso-themecolor:text1'>Typical Industry Pattern (Oncology, Rule of Thumb)<o:p></o:p></span></b></p>

<ul style='margin-top:0in' type=disc>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l8 level1 lfo22;
     tab-stops:list .5in left 92.0pt'>~30%: <b>Single RP2D</b><o:p></o:p></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l8 level1 lfo22;
     tab-stops:list .5in left 92.0pt'>~4050%: <b>RP2D + exploratory cohort</b><o:p></o:p></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l8 level1 lfo22;
     tab-stops:list .5in left 92.0pt'>~1520%: <b>Randomized or adaptive dose
     selection</b><o:p></o:p></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l8 level1 lfo22;
     tab-stops:list .5in left 92.0pt'>&lt;10%: <b>Highly complex dose
     optimization</b><o:p></o:p></li>
</ul>

<div class=MsoNormal align=center style='text-align:center;tab-stops:92.0pt'><span
style='color:black;mso-themecolor:text1'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal style='tab-stops:92.0pt'><b><span style='color:black;
mso-themecolor:text1'>One-Sentence Takeaway<o:p></o:p></span></b></p>

<p class=MsoNormal style='tab-stops:92.0pt'><b><span style='color:black;
mso-themecolor:text1'>Phase II <span class=GramE>dose</span> strategy should be
chosen based on how <span class=GramE>much dose</span> uncertainty remains and
how costly it would be to be wrong in Phase III.</span></b><span
style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>

<p class=MsoNormal style='tab-stops:92.0pt'><span style='color:black;
mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<span style='font-size:12.0pt;line-height:115%;font-family:"Aptos",sans-serif;
mso-ascii-theme-font:minor-latin;mso-fareast-font-family:DengXian;mso-fareast-theme-font:
minor-fareast;mso-hansi-theme-font:minor-latin;mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:minor-bidi;mso-ansi-language:EN-US;mso-fareast-language:
ZH-CN;mso-bidi-language:AR-SA'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Oncology
Phase I Go / No-Go Example<o:p></o:p></span></b></p>

<p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Study Type<o:p></o:p></span></b></p>

<p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>First-in-Human
(FIH) Phase I, dose escalation with expansion</span></b><span style='color:
black;mso-themecolor:text1'><o:p></o:p></span></p>

<div class=MsoNormal align=center style='text-align:center'><span
style='color:black;mso-themecolor:text1'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Background<o:p></o:p></span></b></p>

<ul style='margin-top:0in' type=disc>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l17 level1 lfo4;
     tab-stops:list .5in'><b>Drug class:</b> Novel targeted small-molecule
     (first-in-class)<o:p></o:p></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l17 level1 lfo4;
     tab-stops:list .5in'><b>Indication:</b> Advanced solid tumors (pan-tumor)<o:p></o:p></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l17 level1 lfo4;
     tab-stops:list .5in'><b>Design:</b><o:p></o:p></li>
 <ul style='margin-top:0in' type=circle>
  <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l17 level2 lfo4;
      tab-stops:list 1.0in'>Dose escalation: BOIN design<o:p></o:p></li>
  <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l17 level2 lfo4;
      tab-stops:list 1.0in'>DLT window: 28 days<o:p></o:p></li>
  <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l17 level2 lfo4;
      tab-stops:list 1.0in'>Dose expansion at RP2D<o:p></o:p></li>
 </ul>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l17 level1 lfo4;
     tab-stops:list .5in'><b>Primary objectives:</b><o:p></o:p></li>
 <ul style='margin-top:0in' type=circle>
  <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l17 level2 lfo4;
      tab-stops:list 1.0in'>Safety and tolerability<o:p></o:p></li>
  <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l17 level2 lfo4;
      tab-stops:list 1.0in'>MTD / RP2D determination<o:p></o:p></li>
 </ul>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l17 level1 lfo4;
     tab-stops:list .5in'><b>Secondary objectives:</b><o:p></o:p></li>
 <ul style='margin-top:0in' type=circle>
  <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l17 level2 lfo4;
      tab-stops:list 1.0in'>PK<o:p></o:p></li>
  <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l17 level2 lfo4;
      tab-stops:list 1.0in'>Preliminary anti-tumor activity (RECIST 1.1)<o:p></o:p></li>
 </ul>
</ul>

<div class=MsoNormal align=center style='text-align:center'><span
style='color:black;mso-themecolor:text1'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Key Phase
I Data at Decision Point<o:p></o:p></span></b></p>

<p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>1. Safety
and Tolerability<o:p></o:p></span></b></p>

<ul style='margin-top:0in' type=disc>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l0 level1 lfo5;
     tab-stops:list .5in'>6 dose levels evaluated<o:p></o:p></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l0 level1 lfo5;
     tab-stops:list .5in'><b>MTD not reached</b><o:p></o:p></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l0 level1 lfo5;
     tab-stops:list .5in'><b>RP2D selected</b> based on PK + safety<o:p></o:p></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l0 level1 lfo5;
     tab-stops:list .5in'><b>Grade &#8805;3 TRAEs:</b> 18%<o:p></o:p></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l0 level1 lfo5;
     tab-stops:list .5in'><b>DLTs:</b> 2 / 24 patients (8%)<o:p></o:p></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l0 level1 lfo5;
     tab-stops:list .5in'>DLTs were <b>predictable and manageable</b>
     (hematologic)<o:p></o:p></li>
</ul>

<div class=MsoNormal align=center style='text-align:center'><span
style='color:black;mso-themecolor:text1'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>2.
Pharmacokinetics<o:p></o:p></span></b></p>

<ul style='margin-top:0in' type=disc>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l20 level1 lfo6;
     tab-stops:list .5in'><b>Dose-proportional exposure</b><o:p></o:p></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l20 level1 lfo6;
     tab-stops:list .5in'>RP2D exposure:<o:p></o:p></li>
 <ul style='margin-top:0in' type=circle>
  <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l20 level2 lfo6;
      tab-stops:list 1.0in'>Exceeds preclinical <b>IC90</b><o:p></o:p></li>
  <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l20 level2 lfo6;
      tab-stops:list 1.0in'>Achieves <span class=GramE>steady-state</span><o:p></o:p></li>
 </ul>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l20 level1 lfo6;
     tab-stops:list .5in'>No unexpected accumulation<o:p></o:p></li>
</ul>

<div class=MsoNormal align=center style='text-align:center'><span
style='color:black;mso-themecolor:text1'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>3.
Preliminary Anti-Tumor Activity<o:p></o:p></span></b></p>

<p class=MsoNormal><i><span style='color:black;mso-themecolor:text1'>(Not a
primary Phase I objective, but critical for Go / No-Go)</span></i><span
style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>

<ul style='margin-top:0in' type=disc>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l7 level1 lfo7;
     tab-stops:list .5in'><b>Evaluable patients:</b> 28<o:p></o:p></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l7 level1 lfo7;
     tab-stops:list .5in'><b>Partial responses (PR):</b> 4 patients (14%)<o:p></o:p></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l7 level1 lfo7;
     tab-stops:list .5in'><b>Stable disease &#8805;6 months:</b> 6 patients
     (21%)<o:p></o:p></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l7 level1 lfo7;
     tab-stops:list .5in'><b>Disease control rate (DCR):</b> 36%<o:p></o:p></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l7 level1 lfo7;
     tab-stops:list .5in'><b>2 PRs ongoing &#8805;9 months</b><o:p></o:p></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l7 level1 lfo7;
     tab-stops:list .5in'>Responses enriched in <b>biomarker-positive tumors</b><o:p></o:p></li>
</ul>

<div class=MsoNormal align=center style='text-align:center'><span
style='color:black;mso-themecolor:text1'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Phase I Go
/ No-Go Evaluation<o:p></o:p></span></b></p>

<div class=MsoNormal align=center style='text-align:center'><span
style='color:black;mso-themecolor:text1'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>A. Safety
(Hard Gate)<o:p></o:p></span></b></p>

<table class=MsoNormalTable border=0 cellspacing=3 cellpadding=0
 style='mso-cellspacing:1.5pt;mso-yfti-tbllook:1184'>
 <thead>
  <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Criterion<o:p></o:p></span></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Outcome<o:p></o:p></span></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Decision<o:p></o:p></span></b></p>
   </td>
  </tr>
 </thead>
 <tr style='mso-yfti-irow:1'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>DLT rate<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>8%<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Go</span></b><span
  style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>Predictability
  of toxicity<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>Yes<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Go</span></b><span
  style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>Irreversible
  toxicity<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>None<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Go</span></b><span
  style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4;mso-yfti-lastrow:yes'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>Treatment-related
  deaths<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>None<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Go</span></b><span
  style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Conclusion:</span></b><span
style='color:black;mso-themecolor:text1'> <b>Go</b><o:p></o:p></span></p>

<div class=MsoNormal align=center style='text-align:center'><span
style='color:black;mso-themecolor:text1'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>B. PK and
Dose Justification (Core Phase I Requirement)<o:p></o:p></span></b></p>

<table class=MsoNormalTable border=0 cellspacing=3 cellpadding=0
 style='mso-cellspacing:1.5pt;mso-yfti-tbllook:1184'>
 <thead>
  <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Criterion<o:p></o:p></span></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Outcome<o:p></o:p></span></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Decision<o:p></o:p></span></b></p>
   </td>
  </tr>
 </thead>
 <tr style='mso-yfti-irow:1'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>Doseexposure
  relationship<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>Linear<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Go</span></b><span
  style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>RP2D
  scientifically justified<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>Yes<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Go</span></b><span
  style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>Target
  coverage at RP2D<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>IC90
  covered<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Go</span></b><span
  style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4;mso-yfti-lastrow:yes'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span class=GramE><span style='color:black;mso-themecolor:
  text1'>Dosing</span></span><span style='color:black;mso-themecolor:text1'>
  schedule feasible<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>Yes<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Go</span></b><span
  style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Conclusion:</span></b><span
style='color:black;mso-themecolor:text1'> <b>Go</b><o:p></o:p></span></p>

<div class=MsoNormal align=center style='text-align:center'><span
style='color:black;mso-themecolor:text1'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>C.
Preliminary Anti-Tumor Activity (Value Driver)<o:p></o:p></span></b></p>

<table class=MsoNormalTable border=0 cellspacing=3 cellpadding=0
 style='mso-cellspacing:1.5pt;mso-yfti-tbllook:1184'>
 <thead>
  <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Criterion<o:p></o:p></span></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Outcome<o:p></o:p></span></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Decision<o:p></o:p></span></b></p>
   </td>
  </tr>
 </thead>
 <tr style='mso-yfti-irow:1'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>Objective
  responses observed<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>Yes<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Go</span></b><span
  style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>Durability
  of responses<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>&#8805;9
  months<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Strong
  Go</span></b><span style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>Biological
  plausibility<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>Yes<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Go</span></b><span
  style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4;mso-yfti-lastrow:yes'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>Activity
  driven only by SD<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>No<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Go</span></b><span
  style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Note:</span></b><span
style='color:black;mso-themecolor:text1'> Objective responses are not required
in Phase I,<br>
but <b>durable PRs represent a strong Go signal</b>.<o:p></o:p></span></p>

<p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Conclusion:</span></b><span
style='color:black;mso-themecolor:text1'> <b>Strong Go</b><o:p></o:p></span></p>

<div class=MsoNormal align=center style='text-align:center'><span
style='color:black;mso-themecolor:text1'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>D.
Biological and Mechanistic Support<o:p></o:p></span></b></p>

<table class=MsoNormalTable border=0 cellspacing=3 cellpadding=0
 style='mso-cellspacing:1.5pt;mso-yfti-tbllook:1184'>
 <thead>
  <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Criterion<o:p></o:p></span></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Outcome<o:p></o:p></span></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Decision<o:p></o:p></span></b></p>
   </td>
  </tr>
 </thead>
 <tr style='mso-yfti-irow:1'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span class=SpellE><span style='color:black;mso-themecolor:
  text1'>MoA</span></span><span style='color:black;mso-themecolor:text1'>
  consistent with responses<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>Yes<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Go</span></b><span
  style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>Biomarkerresponse
  relationship<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>Clear
  enrichment<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Go</span></b><span
  style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3;mso-yfti-lastrow:yes'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>Exposureresponse
  trend<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>Observed<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Go</span></b><span
  style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Conclusion:</span></b><span
style='color:black;mso-themecolor:text1'> <b>Go</b><o:p></o:p></span></p>

<div class=MsoNormal align=center style='text-align:center'><span
style='color:black;mso-themecolor:text1'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>E.
Readiness for Phase II<o:p></o:p></span></b></p>

<table class=MsoNormalTable border=0 cellspacing=3 cellpadding=0
 style='mso-cellspacing:1.5pt;mso-yfti-tbllook:1184'>
 <thead>
  <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Criterion<o:p></o:p></span></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Outcome<o:p></o:p></span></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Decision<o:p></o:p></span></b></p>
   </td>
  </tr>
 </thead>
 <tr style='mso-yfti-irow:1'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>RP2D
  defined<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>Yes<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Go</span></b><span
  style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>Target
  population identifiable<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>Yes<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Go</span></b><span
  style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>Phase II
  design feasible<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>Yes<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Go</span></b><span
  style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4;mso-yfti-lastrow:yes'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>Competitive
  landscape<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><span style='color:black;mso-themecolor:text1'>Acceptable<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Go</span></b><span
  style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Conclusion:</span></b><span
style='color:black;mso-themecolor:text1'> <b>Go</b><o:p></o:p></span></p>

<div class=MsoNormal align=center style='text-align:center'><span
style='color:black;mso-themecolor:text1'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Final Go /
No-Go Decision<o:p></o:p></span></b></p>

<p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Decision:
GO &#8594; Proceed to Phase II (biomarker-enriched design)</span></b><span
style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>

<div class=MsoNormal align=center style='text-align:center'><span
style='color:black;mso-themecolor:text1'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>What Would
Have Led to a No-Go?<o:p></o:p></span></b></p>

<p class=MsoNormal><span style='color:black;mso-themecolor:text1'>Common
oncology Phase I <b>No-Go scenarios</b>:<o:p></o:p></span></p>

<ul style='margin-top:0in' type=disc>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l9 level1 lfo8;
     tab-stops:list .5in'>RP2D exposure fails to reach biologically active
     levels<o:p></o:p></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l9 level1 lfo8;
     tab-stops:list .5in'>DLTs are unpredictable or cumulative<o:p></o:p></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l9 level1 lfo8;
     tab-stops:list .5in'><b>No objective responses or durable disease control</b><o:p></o:p></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l9 level1 lfo8;
     tab-stops:list .5in'>Lack of mechanistic coherence<o:p></o:p></li>
 <li class=MsoNormal style='color:black;mso-themecolor:text1;mso-list:l9 level1 lfo8;
     tab-stops:list .5in'>Safety acceptable but <b>no evidence of clinical
     activity</b><o:p></o:p></li>
</ul>

<div class=MsoNormal align=center style='text-align:center'><span
style='color:black;mso-themecolor:text1'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>Key Phase
I Decision Principle (Oncology)<o:p></o:p></span></b></p>

<p class=MsoNormal><b><span style='color:black;mso-themecolor:text1'>In
oncology Phase I, safety alone is not sufficient.<br>
The question is whether acceptable safety reveals any biologically or
clinically meaningful signal worth validating.</span></b><span
style='color:black;mso-themecolor:text1'><o:p></o:p></span></p>

<span style='font-size:12.0pt;line-height:115%;font-family:"Aptos",sans-serif;
mso-ascii-theme-font:minor-latin;mso-fareast-font-family:DengXian;mso-fareast-theme-font:
minor-fareast;mso-hansi-theme-font:minor-latin;mso-bidi-font-family:"Times New Roman";
mso-bidi-theme-font:minor-bidi;color:#0070C0;mso-ansi-language:EN-US;
mso-fareast-language:ZH-CN;mso-bidi-language:AR-SA'><br clear=all
style='mso-special-character:line-break;page-break-before:always'>
</span>

<p class=MsoNormal><span style='color:#0070C0'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal;mso-outline-level:1'><b><span style='font-size:24.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:18.0pt;mso-ligatures:none'>Example: How RP2D Is Determined in
an Oncology Phase I Study<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal;mso-outline-level:2'><b><span style='font-size:18.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-ligatures:none'>Study Background<o:p></o:p></span></b></p>

<ul type=disc>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:normal;mso-list:l11 level1 lfo9;tab-stops:list .5in'><b><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'>Drug class:</span></b><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'> First-in-class targeted
     small-molecule<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:normal;mso-list:l11 level1 lfo9;tab-stops:list .5in'><b><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'>Indication:</span></b><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'> Advanced solid tumors<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:normal;mso-list:l11 level1 lfo9;tab-stops:list .5in'><b><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'>Design:</span></b><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'> BOIN dose-escalation with
     expansion<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:normal;mso-list:l11 level1 lfo9;tab-stops:list .5in'><b><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'>Dosing schedule:</span></b><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'> QD continuous dosing<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:normal;mso-list:l11 level1 lfo9;tab-stops:list .5in'><b><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'>DLT window:</span></b><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'> 28 days<o:p></o:p></span></li>
</ul>

<div class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
line-height:normal'><span style='font-family:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
none'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal;mso-outline-level:2'><b><span style='font-size:18.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-ligatures:none'>Key Principle (Critical)<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal'><b><span style='font-family:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
none'>RP2D is not necessarily the MTD.</span></b><span style='font-family:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
none'><br>
<b>RP2D is the dose that provides the optimal balance of safety, PK, PD, and
preliminary efficacy.</b><o:p></o:p></span></p>

<div class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
line-height:normal'><span style='font-family:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
none'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal;mso-outline-level:2'><b><span style='font-size:18.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-ligatures:none'>Dose-Escalation Summary<o:p></o:p></span></b></p>

<table class=MsoNormalTable border=0 cellspacing=3 cellpadding=0
 style='mso-cellspacing:1.5pt;mso-yfti-tbllook:1184'>
 <thead>
  <tr style='mso-yfti-irow:0;mso-yfti-firstrow:yes'>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
   line-height:normal'><b><span style='font-family:"Times New Roman",serif;
   mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
   none'>Dose Level<o:p></o:p></span></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
   line-height:normal'><b><span style='font-family:"Times New Roman",serif;
   mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
   none'>Dose (mg QD)<o:p></o:p></span></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
   line-height:normal'><b><span style='font-family:"Times New Roman",serif;
   mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
   none'>DLT (n/N)<o:p></o:p></span></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
   line-height:normal'><b><span style='font-family:"Times New Roman",serif;
   mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
   none'>Grade &#8805;3 TRAE<o:p></o:p></span></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
   line-height:normal'><b><span style='font-family:"Times New Roman",serif;
   mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
   none'>PK Exposure (AUC)<o:p></o:p></span></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
   line-height:normal'><span class=GramE><b><span style='font-family:"Times New Roman",serif;
   mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
   none'>PD</span></b></span><b><span style='font-family:"Times New Roman",serif;
   mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
   none'> Target Inhibition<o:p></o:p></span></b></p>
   </td>
   <td style='padding:.75pt .75pt .75pt .75pt'>
   <p class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
   line-height:normal'><b><span style='font-family:"Times New Roman",serif;
   mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
   none'>PR<o:p></o:p></span></b></p>
   </td>
  </tr>
 </thead>
 <tr style='mso-yfti-irow:1'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>DL1<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>50<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>0/3<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>0<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>Low<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>30%<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>0<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:2'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>DL2<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>100<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>0/3<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>0<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>&#8593;<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>45%<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>0<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:3'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>DL3<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>200<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>1/6<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>1<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>&#8593;&#8593;<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>65%<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>0<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:4'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>DL4<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>300<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>1/6<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>2<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>&#8593;&#8593;&#8593;<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>80%<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>1<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:5'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>DL5<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>400<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>2/6<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>3<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>&#8593;&#8593;&#8593;<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>85%<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>1<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style='mso-yfti-irow:6;mso-yfti-lastrow:yes'>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>DL6<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>500<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>3/6<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>4<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>Plateau<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>90%<o:p></o:p></span></p>
  </td>
  <td style='padding:.75pt .75pt .75pt .75pt'>
  <p class=MsoNormal style='margin-bottom:0in;line-height:normal'><span
  style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
  mso-font-kerning:0pt;mso-ligatures:none'>0<o:p></o:p></span></p>
  </td>
 </tr>
</table>

<div class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
line-height:normal'><span style='font-family:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
none'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal;mso-outline-level:2'><b><span style='font-size:18.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-ligatures:none'>Step-by-Step RP2D Determination<o:p></o:p></span></b></p>

<div class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
line-height:normal'><span style='font-family:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
none'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal;mso-outline-level:3'><b><span style='font-size:13.5pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-ligatures:none'>Step 1: Identify the MTD Range<o:p></o:p></span></b></p>

<ul type=disc>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:normal;mso-list:l16 level1 lfo10;tab-stops:list .5in'><b><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'>500 mg:</span></b><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'> DLTs in 3/6 patients (50%)
     &#8594; unacceptable<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:normal;mso-list:l16 level1 lfo10;tab-stops:list .5in'><b><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'>400 mg:</span></b><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'> DLTs in 2/6 patients (33%)
     &#8594; borderline<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:normal;mso-list:l16 level1 lfo10;tab-stops:list .5in'><b><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'>300 mg:</span></b><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'> DLTs in 1/6 patients (17%)
     &#8594; acceptable<o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal'><b><span style='font-family:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
none'>MTD estimated around 300400 mg.</span></b><span style='font-family:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
none'><o:p></o:p></span></p>

<div class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
line-height:normal'><span style='font-family:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
none'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal;mso-outline-level:3'><b><span style='font-size:13.5pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-ligatures:none'>Step 2: Evaluate PK Saturation<o:p></o:p></span></b></p>

<ul type=disc>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:normal;mso-list:l2 level1 lfo11;tab-stops:list .5in'><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'>Exposure increased from 300
     &#8594; 400 mg, but <b>incremental gain was modest</b><o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:normal;mso-list:l2 level1 lfo11;tab-stops:list .5in'><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'>From 400 &#8594; 500 mg, <b>no
     meaningful increase in exposure</b><o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal'><b><span style='font-family:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
none'>PK approached a plateau at &#8805;300 mg.</span></b><span
style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-ligatures:none'><o:p></o:p></span></p>

<div class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
line-height:normal'><span style='font-family:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
none'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal;mso-outline-level:3'><b><span style='font-size:13.5pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-ligatures:none'>Step 3: Assess Pharmacodynamic (PD)
Target Engagement<o:p></o:p></span></b></p>

<ul type=disc>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:normal;mso-list:l21 level1 lfo12;tab-stops:list .5in'><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'>300 mg: ~80% target inhibition<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:normal;mso-list:l21 level1 lfo12;tab-stops:list .5in'><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'>400 mg: ~85%<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:normal;mso-list:l21 level1 lfo12;tab-stops:list .5in'><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'>500 mg: ~90%<o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal'><b><span style='font-family:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
none'>Near-maximal biological activity achieved at 300 mg.</span></b><span
style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-ligatures:none'><o:p></o:p></span></p>

<div class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
line-height:normal'><span style='font-family:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
none'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal;mso-outline-level:3'><b><span style='font-size:13.5pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-ligatures:none'>Step 4: Review Preliminary Anti-Tumor
Activity<o:p></o:p></span></b></p>

<ul type=disc>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:normal;mso-list:l3 level1 lfo13;tab-stops:list .5in'><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'>Partial responses observed at:<o:p></o:p></span></li>
 <ul type=circle>
  <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:
      auto;line-height:normal;mso-list:l3 level2 lfo13;tab-stops:list 1.0in'><b><span
      style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
      mso-font-kerning:0pt;mso-ligatures:none'>300 mg</span></b><span
      style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
      mso-font-kerning:0pt;mso-ligatures:none'><o:p></o:p></span></li>
  <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:
      auto;line-height:normal;mso-list:l3 level2 lfo13;tab-stops:list 1.0in'><b><span
      style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
      mso-font-kerning:0pt;mso-ligatures:none'>400 mg</span></b><span
      style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
      mso-font-kerning:0pt;mso-ligatures:none'><o:p></o:p></span></li>
 </ul>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:normal;mso-list:l3 level1 lfo13;tab-stops:list .5in'><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'>No additional responses at 500 mg<o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal'><b><span style='font-family:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
none'>Higher doses did not improve efficacy.</span></b><span style='font-family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
0pt;mso-ligatures:none'><o:p></o:p></span></p>

<div class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
line-height:normal'><span style='font-family:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
none'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal;mso-outline-level:3'><b><span style='font-size:13.5pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-ligatures:none'>Step 5: Examine Safety Trends Beyond
DLTs<o:p></o:p></span></b></p>

<ul type=disc>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:normal;mso-list:l14 level1 lfo14;tab-stops:list .5in'><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'>Grade &#8805;3 TRAEs increased
     with dose:<o:p></o:p></span></li>
 <ul type=circle>
  <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:
      auto;line-height:normal;mso-list:l14 level2 lfo14;tab-stops:list 1.0in'><span
      style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
      mso-font-kerning:0pt;mso-ligatures:none'>300 mg: 2 patients<o:p></o:p></span></li>
  <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:
      auto;line-height:normal;mso-list:l14 level2 lfo14;tab-stops:list 1.0in'><span
      style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
      mso-font-kerning:0pt;mso-ligatures:none'>400 mg: 3 patients<o:p></o:p></span></li>
  <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:
      auto;line-height:normal;mso-list:l14 level2 lfo14;tab-stops:list 1.0in'><span
      style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
      mso-font-kerning:0pt;mso-ligatures:none'>500 mg: 4 patients<o:p></o:p></span></li>
 </ul>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:normal;mso-list:l14 level1 lfo14;tab-stops:list .5in'><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'>Evidence of cumulative toxicity
     at higher doses<o:p></o:p></span></li>
</ul>

<div class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
line-height:normal'><span style='font-family:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
none'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal;mso-outline-level:2'><b><span style='font-size:18.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-ligatures:none'>Integrated Dose-Selection Decision<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal;mso-outline-level:3'><b><span style='font-size:13.5pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-ligatures:none'>Decision Framework<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal'><b><span style='font-family:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
none'>Select the lowest dose that achieves:</span></b><span style='font-family:
"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";mso-font-kerning:
0pt;mso-ligatures:none'><o:p></o:p></span></p>

<ul type=disc>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:normal;mso-list:l6 level1 lfo15;tab-stops:list .5in'><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'>Adequate target engagement<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:normal;mso-list:l6 level1 lfo15;tab-stops:list .5in'><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'>Demonstrable clinical activity<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:normal;mso-list:l6 level1 lfo15;tab-stops:list .5in'><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'>Acceptable and manageable safety
     for chronic dosing<o:p></o:p></span></li>
</ul>

<div class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
line-height:normal'><span style='font-family:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
none'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal;mso-outline-level:2'><b><span style='font-size:18.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-ligatures:none'>Final RP2D Selection<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal'><b><span style='font-family:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
none'>RP2D = 300 mg QD</span></b><span style='font-family:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
none'><o:p></o:p></span></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal;mso-outline-level:3'><b><span style='font-size:13.5pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-ligatures:none'>Rationale<o:p></o:p></span></b></p>

<ul type=disc>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:normal;mso-list:l5 level1 lfo16;tab-stops:list .5in'><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'>Below or at the lower end of the
     MTD range<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:normal;mso-list:l5 level1 lfo16;tab-stops:list .5in'><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'>PK exposure sufficient and near
     saturation<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:normal;mso-list:l5 level1 lfo16;tab-stops:list .5in'><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'>PD shows near-maximal target
     inhibition<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:normal;mso-list:l5 level1 lfo16;tab-stops:list .5in'><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'>Objective responses observed<o:p></o:p></span></li>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:normal;mso-list:l5 level1 lfo16;tab-stops:list .5in'><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'>Superior safety margin compared
     with higher doses<o:p></o:p></span></li>
</ul>

<div class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
line-height:normal'><span style='font-family:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
none'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal;mso-outline-level:2'><b><span style='font-size:18.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-ligatures:none'>Common Pitfalls to Avoid<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal;mso-outline-level:3'><b><span style='font-size:13.5pt;
font-family:"Segoe UI Emoji",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:"Segoe UI Emoji";mso-font-kerning:0pt;mso-ligatures:none'>&#10060;</span></b><b><span
style='font-size:13.5pt;font-family:"Times New Roman",serif;mso-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-ligatures:none'> Equating MTD with
RP2D<o:p></o:p></span></b></p>

<ul type=disc>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:normal;mso-list:l19 level1 lfo17;tab-stops:list .5in'><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'>Often leads to excessive toxicity
     in Phase II<o:p></o:p></span></li>
</ul>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal;mso-outline-level:3'><b><span style='font-size:13.5pt;
font-family:"Segoe UI Emoji",sans-serif;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:"Segoe UI Emoji";mso-font-kerning:0pt;mso-ligatures:none'>&#10060;</span></b><b><span
style='font-size:13.5pt;font-family:"Times New Roman",serif;mso-fareast-font-family:
"Times New Roman";mso-font-kerning:0pt;mso-ligatures:none'> Basing RP2D solely
on DLTs<o:p></o:p></span></b></p>

<ul type=disc>
 <li class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
     line-height:normal;mso-list:l4 level1 lfo18;tab-stops:list .5in'><span
     class=GramE><span style='font-family:"Times New Roman",serif;mso-fareast-font-family:
     "Times New Roman";mso-font-kerning:0pt;mso-ligatures:none'>Ignores</span></span><span
     style='font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
     mso-font-kerning:0pt;mso-ligatures:none'> chronic toxicity, PK saturation,
     and PD data<o:p></o:p></span></li>
</ul>

<div class=MsoNormal align=center style='margin-bottom:0in;text-align:center;
line-height:normal'><span style='font-family:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
none'>

<hr size=2 width="100%" align=center>

</span></div>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal;mso-outline-level:2'><b><span style='font-size:18.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roman";
mso-font-kerning:0pt;mso-ligatures:none'>One-Sentence Takeaway<o:p></o:p></span></b></p>

<p class=MsoNormal style='mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;
line-height:normal'><b><span style='font-family:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
none'>In oncology Phase I studies, RP2D is the dose most likely to deliver a
favorable long-term riskbenefit profilenot simply the highest tolerable dose.<o:p></o:p></span></b></p>

<p class=MsoNormal><b><span style='font-family:"Times New Roman",serif;
mso-fareast-font-family:"Times New Roman";mso-font-kerning:0pt;mso-ligatures:
none'>If there is sufficient PK/PD/efficacy and safety evidence for 300 mg, a
single RP2D should be prioritized to accelerate development; if there are
modeling or biological concerns regarding 350 mg, a small exploratory cohort
should be conducted first, and then a decision should be made based on
pre-defined trigger rules whether to proceed to a randomized dose comparison. </span></b><b><span
style='font-family:"Times New Roman",serif;mso-font-kerning:0pt;mso-ligatures:
none'><o:p></o:p></span></b></p>

</div>

</body>

</html>
